Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Intermediate- and Long-term Results After Adjustable Transobturator Male System Implantation.

Urology·2024
Same author

Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.

Cancers·2023
Same author

Pre-test probability of sexually transmitted infections in persons presenting to a STI clinic: A prospective study.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2023
Same author

Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.

World journal of urology·2023
Same author

'Case of the Month' from the Medical University of Graz, Austria: ulcus durum mimicking squamous cell carcinoma.

BJU international·2023

Related Experiment Video

Updated: Feb 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

901

Predicting outcomes in patients with urologic cancers.

Pierre I Karakiewicz1, Georg C Hutterer

  • 1Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada. pierre.karakiewicz@umontreal.ca

Current Opinion in Supportive and Palliative Care
|August 8, 2008
PubMed
Summary

This review summarizes predictive and prognostic models for bladder, kidney, and prostate cancer outcomes. Accurate, evidence-based models exist to predict cancer control in urologic malignancies.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

942
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.8K

Related Experiment Videos

Last Updated: Feb 19, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

901
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

942
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
09:28

Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis

Published on: May 12, 2019

10.8K

Area of Science:

  • Urology
  • Oncology
  • Medical Informatics

Background:

  • Predictive and prognostic models are crucial for managing urologic malignancies.
  • Identifying robust models aids clinical decision-making and patient care.

Purpose of the Study:

  • To systematically review existing predictive and prognostic models for bladder, kidney, and prostate cancer.
  • To assess the availability and scope of models addressing oncological outcomes.

Main Methods:

  • A systematic literature review was conducted using PubMed.
  • Keywords included 'diagnosis', 'stage', 'prognosis', and 'nomograms' for specific cancers.
  • 70 English-language articles were selected based on relevance, quality, and evidence level.

Main Results:

  • Six models for bladder cancer natural history.
  • 15 models for kidney cancer (recurrence, survival).
  • 31 models for prostate cancer (biopsy, staging, recurrence, survival).

Conclusions:

  • Numerous evidence-based models accurately predict cancer control outcomes in urologic malignancies.
  • These models support informed clinical practice for bladder, kidney, and prostate cancer patients.